Home / Going-concern warnings / Serina Therapeutics, Inc.

3/5Serina Therapeutics, Inc. (SER): Going-concern doubt

Filed 2025-11-13 路 Form 10-Q 路 Accession 0001708599-25-000133 nano

Market data

Price before filing: $4.02 (2025-11-12 close, split/dividend-adjusted)
Market cap at flag: $39.9M (2025-11-13) 路 Latest: $28.2M (2026-10-16)

What happened next

WindowSERSPYvs SPY
30 days-25.6%-0.4%-25.2%2025-12-15
90 days-53.7%+1.6%-55.3%2026-02-11
180 days-59.5%+8.6%-68.1%2026-05-12

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: 1 insider sold $496K (11 sales)
30 days after: 1 insider sold $94K (9 sales)

DateInsiderTypeSharesPriceValue10b5-1 planSource
2025-08-18Moreadith Randall
Chief Scientific Officer
Sale2,227$5.25$12KyesForm 4
2025-08-20Moreadith Randall
Chief Scientific Officer
Sale2,077$5.10$11KyesForm 4
2025-08-25Moreadith Randall
Chief Scientific Officer
Sale2,042$5.65$12KyesForm 4
2025-08-26Moreadith Randall
Chief Scientific Officer
Sale45,632$7.01$320KyesForm 4
2025-10-13Moreadith Randall
Chief Scientific Officer
Sale4,326$5.20$22KyesForm 4
2025-10-20Moreadith Randall
Chief Scientific Officer
Sale6,500$4.97$32KyesForm 4
2025-10-27Moreadith Randall
Chief Scientific Officer
Sale949$5.19$5KyesForm 4
2025-10-28Moreadith Randall
Chief Scientific Officer
Sale5,551$4.96$28KyesForm 4
2025-11-04Moreadith Randall
Chief Scientific Officer
Sale3,102$4.40$14KyesForm 4
2025-11-05Moreadith Randall
Chief Scientific Officer
Sale3,398$4.24$14KyesForm 4
2025-11-10Moreadith Randall
Chief Scientific Officer
Sale6,500$4.10$27KyesForm 4
2025-11-13: red flag filed
2025-11-18Moreadith Randall
Chief Scientific Officer
Sale6,500$3.75$24KyesForm 4
2025-11-24Moreadith Randall
Chief Scientific Officer
Sale535$3.94$2KyesForm 4
2025-11-25Moreadith Randall
Chief Scientific Officer
Sale5,965$3.90$23KyesForm 4
2025-12-02Moreadith Randall
Chief Scientific Officer
Sale1,500$3.91$6KyesForm 4
2025-12-03Moreadith Randall
Chief Scientific Officer
Sale5,000$3.52$18KyesForm 4
2025-12-09Moreadith Randall
Chief Scientific Officer
Sale600$3.31$2KyesForm 4
2025-12-10Moreadith Randall
Chief Scientific Officer
Sale645$3.35$2KyesForm 4
2025-12-11Moreadith Randall
Chief Scientific Officer
Sale3,555$3.24$12KyesForm 4
2025-12-12Moreadith Randall
Chief Scientific Officer
Sale1,700$3.26$6KyesForm 4

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-08-15 to 2025-12-13. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"As such, there is substantial doubt about the Company's ability to continue as a going concern."

Quoted from the filing. Source

What this means

The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.

Source: management disclosure in Form 10-Q (period 2025-09-30)

Why this score: quarterly (unaudited) disclosure

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.

Form not showing? Subscribe on beehiiv →

Newsletter delivered by beehiiv. See our privacy policy.